[July 31, 2014] |
|
Labs, Pathologists Prepare for a Demanding Era of Reform: Top Industry Executives to Convene on Capitol Hill to Interpret Complex Market Changes, Share New Growth Opportunities
KEENE, N.H. --(Business Wire)--
G2 (News - Alert) Intelligence - a 30+ year leader in research, reporting, and analysis
on the business of the diagnostic lab industry - announced today the
full agenda
and list of speakers
for Lab Institute 2014: Inflection Point for Labs, the
one event where lab medicine, business and technology, and public policy
meet. The event will be held at a new venue in the heart of our
nation's capital, October 15-17, at the Hyatt Regency Washington DC on
Capitol Hill.
"Clinical laboratory, anatomic pathology, and diagnostic testing
executives are facing a crucial period of transition. And, the time for
companies to reset their competitive and profitability targets by
gaining a deeper understanding of market dynamics reshaping the lab and
pathology sectors is now," says Dennis Weissman, G2
Intelligence's Founder and Executive Editor, and Lab Institute Program
Chair. G2 Intelligence's Managing Director, Stephanie Murg, adds "This
year's Institute is focused on addressing the confluence of
unprecedented changes impacting the entire industry - and steps
organizations can take to grow and remain profitable."
G2 is pleased to announce five keynote speakers, all renowned
industry leaders in their fields.
-
Marc D. Grodman, M.D., Chairman, President and CEO,
Bio-Reference Laboratories, who will address the State of the Lab
Industry in a dynamic interactive session
-
James Crawford, M.D., Ph.D., Executive Director and Senior Vice
President for Laboratory Services, North Shore-LIJ Health System;
Chair, Department of Pathology, Hofstra North Shore-LIJ School of
Medicine - Coordinated Care: The Pivot Point for Pathology and
Laboratory Services
-
Paul Keckley, Ph.D., Managing Director, Navigant Healthcare and
Navigant Center for Healthcare Research and Policy Analysis - The
Acceleration of the ACA: How to Prepare for Health Reform 2.0
-
Michael Reitermann, CEO, Siemens (News - Alert) Healthcare Diagnostics - Raising
the Bar for Clinical Diagnostics
-
George Poste, D.V.M., D.Sc., Ph.D., Chief Scientist, Complex
Adaptive Systems and Regents' Professor and Del E. Webb Chair in
Health Innovation, Arizona State University - From Big Data to
Sensor Technology: The Future of Lab Testing
The three-day event surrounding the theme, Inflection Point for
Labs, also features an exciting roster of powerful general
sessions, 12 new breakout sessions in four crucial focus areas, and two
pre-conference workshops. Topics include:
-
Lab Town Hall: Taking the Pulse (News - Alert) of an Industry in Flux
-
Reimbursement and Policy Outlook for Labs and Pathologists
-
How the ACA is Driving Medicare Reforms and Market Realignment
-
Lab Pricing, Coverage, and Transparency: Financial and Policy
Implications for Labs
-
The Power of Laboratory Data: Providing Added Value Through Real-Time
Analytics
-
What Can the Galapagos Teach Us About Innovation? A Blueprint for the
Next Generation in Diagnostics
-
Can't-Miss Closing Session! G2 Power Players: The Way Forward for Labs
-
PLUS two half-day intensive workshops: Lab Management Boot Camp:
Improving Bottom-Line Performance; and Reinventing the Hospital
Laboratory in a Changing Market
-
AND a just-announced pst-conference symposium: Getting a Piece of the
Private Payer Market: Lab Contracting Trends, Pricing Realities and
Business Outlook
This
year's distinguished faculty includes:
-
Richard Adams, Administrative Director, Summa Health System/
LabCarePLUS
-
Julie Scott Allen, Government Relations Director and Senior VP,
District Policy Group, Drinker Biddle & Reath; and Washington
representative for the American Association of Bioanalysts & National
Independent Laboratory Association
-
Michael Armstrong, CLS, ASCP, SC, DLM, Chief Operating Officer,
Pacific Rim Pathology and Analytic Pathology Medical Groups
-
Janet Cohen, Director of IT, Genesis Biotechnology Group
-
Neil Crowson, M.D., FCAP, FRCPC, Chief of Staff, St. John Health
System; President, Pathology Laboratory Associates and Vice President,
Regional Medical Laboratory
-
Ben Davis, M.D., Chairman & CEO, PathGroup
-
Lee Dilworth, Chief Legal & Administrative Officer, American Pathology
Partners
-
Brenda Eriksen, M.D., Medical Director of System Laboratories,
Community Healthcare System
-
Keith Fontenot, Managing Director of Government Relations and Public
Policy, Hooper, Lundy & Bookman, PC
-
Katherine Frey, M.D., Director of Patient Blood Utilization
Management, Fairview Southdale Hospital
-
Peter Gosselin, Senior Healthcare Analyst, Bloomberg (News - Alert) Government
-
Peter G. Gudaitis, President, Aculabs Inc.
-
Eric Hammelman, Vice President, Avalere Health
-
Eleanor Herriman, M.D., MBA, Managing Director, Advisory Services, G2
Intelligence
-
Patric Hooper Esq., Founding Partner, Hooper Lundy Bookman
-
Annette Iacono, Vice President, Brookside Clinical Laboratory, Inc.
-
Elaine Jeter, M.D., Medical Director, Palmetto, GBA
-
Tara Kochis, President, Slone Partners
-
Paul Koeppel, Laboratory Business Operations Manager, Intermountain
Healthcare Central Entities
-
Gail Marcus, President and CEO, Calloway Laboratories, Inc.
-
Alan Mertz, President, American Clinical Laboratory Association
-
Kathleen Murphy, Ph.D., Chief Executive Officer, Chi Solutions, Inc.
-
Richard Nicholson, CEO, West Pacific Medical Laboratory
-
Barry Portugal, President, Health Care Development Services, Inc.
-
John H. Scott, Vice President, Advocacy and Policy, College of
American Pathologists
-
Khosrow Shotorbani, CEO, TriCore Reference Laboratories
-
Ajit Singh, Partner, Artiman Ventures
-
Joseph Skrisson, Chief Operating Officer, Dynacare Laboratories
-
Leslie A. Sprick, MT (ASCP), Owner & CEO, Sprick Group
-
Susan Stegall, Owner and CEO of M.S. Stegall and Associates, LLC
-
Michael Snyder, Principal, Clinical Lab Business Solutions LLC
-
Gregory Solak, Vice President, Laboratory Services, Kaleida Health
-
Steve Stonecypher, Director of Managed Care, American Pathology
Partners
-
Scott Taillie, VP of Marketing & Business Development, Alere, Inc.
-
Douglas M. VanOort,, Chairman of the Board of Directors and Chief
Executive Officer, NeoGenomics Laboratories
-
Francisco Velàzquez, M.D., S.M., President and CEO, PAML LLC & PAML
Ventures
-
Diana Voorhees, Principal/CEO, DV & Associates, Inc.
-
Ritu S. Ward, MAOM, MT (ASCP), Assistant Vice President, Carolinas
Laboratory Network
-
Wayne Wecksler, Ph.D., General Manager, Pacific Diagnostic Laboratories
-
Dennis Weissman, Executive Editor, G2 Intelligence and Program Chair
-
Lâle White, Executive Chairman and CEO, XIFIN
-
Christopher Wixom, M.D., President, Pacific Rim Pathology and Analytic
Pathology Medical Groups
-
Jane Pine Wood, Member, McDonald Hopkins
-
Christopher Young, CHC, President, Laboratory Management Support
Services, and Editor, G2 Compliance Advisor
To find out more, or to register for Lab Institute 2014, go to www.LabInstitute.com
or call 1-800-531-1026. Special $200 savings for early registrants is
available through Friday, September 5. Group discounts are available
for three or more people from the same organization. For group
registrations, please call Jeff Watkins at 603-357-8229 to facilitate
your registration, or email [email protected].
About G2 Intelligence
Advancing the Business of Diagnostic Medicine
G2 Intelligence provides timely, accurate, and trusted analysis of
industry and market trends, legal and regulatory developments, and
technology and innovation that directly affect the operations, financial
performance, and competitive position of diagnostic testing laboratories
and related medical services providers.
G2 Intelligence has covered and reported on the diagnostic industry for
over 30 years. Today, the company delivers topical and analytical
periodicals, proprietary research
studies, and custom
advisory services, and through live
and virtual events, facilitates industry meetings and information
exchanges.
G2 Intelligence is a division of Kennedy Information, LLC, a leading
provider of professional markets analysis. Kennedy's parent company,
Bloomberg BNA, a wholly owned subsidiary of Bloomberg, is a leading
source of legal, regulatory, and business information for professionals.
Its network of more than 2,500 reporters, correspondents, and leading
practitioners delivers expert analysis, news, practice tools, and
guidance - the information that matters most to professionals.
More information is available for you at www.G2Intelligence.com.
[ Back To TMCnet.com's Homepage ]
|